A Deep Learning Approach for Automatic Segmentation during Daily MRI-Linac Radiotherapy of Glioblastoma
Adrian L. Breto,Kaylie Cullison,Evangelia I. Zacharaki,Veronica Wallaengen,Danilo Maziero,Kolton Jones,Alessandro Valderrama,Macarena I. de la Fuente,Jessica Meshman,Gregory A. Azzam,John C. Ford,Radka Stoyanova,Eric A. Mellon,Breto,Cullison,Zacharaki,Wallaengen,Maziero,Jones,Valderrama,de la Fuente,Meshman,Azzam,Ford,Stoyanova,Mellon
DOI: https://doi.org/10.3390/cancers15215241
2023-11-01
Cancers
Abstract:Glioblastoma changes during chemoradiotherapy are inferred from high-field MRI before and after treatment but are rarely investigated during radiotherapy. The purpose of this study was to develop a deep learning network to automatically segment glioblastoma tumors on daily treatment set-up scans from the first glioblastoma patients treated on MRI-linac. Glioblastoma patients were prospectively imaged daily during chemoradiotherapy on 0.35T MRI-linac. Tumor and edema (tumor lesion) and resection cavity kinetics throughout the treatment were manually segmented on these daily MRI. Utilizing a convolutional neural network, an automatic segmentation deep learning network was built. A nine-fold cross-validation schema was used to train the network using 80:10:10 for training, validation, and testing. Thirty-six glioblastoma patients were imaged pre-treatment and 30 times during radiotherapy (n = 31 volumes, total of 930 MRIs). The average tumor lesion and resection cavity volumes were 94.56 ± 64.68 cc and 72.44 ± 35.08 cc, respectively. The average Dice similarity coefficient between manual and auto-segmentation for tumor lesion and resection cavity across all patients was 0.67 and 0.84, respectively. This is the first brain lesion segmentation network developed for MRI-linac. The network performed comparably to the only other published network for auto-segmentation of post-operative glioblastoma lesions. Segmented volumes can be utilized for adaptive radiotherapy and propagated across multiple MRI contrasts to create a prognostic model based for glioblastoma on multiparametric MRI.
oncology